Food & Function · 2024 · 49 citations · 69 references
Life SciencesNeurobiologyNeuroscienceInflammationMolecular NeurobiologyNeurodegenerationGut MicrobiomeGut MicrobiotaNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesParkinson DiseasePolysaccharide PropertiesAlpha-synuclein AggregationAlpha-synuclein MisfoldingAlpha-synuclein-targeted TherapyAnti-inflammatory Signaling PathwaysGut Microbiota DysbiosisParkinson Disease PathologyParkinson’s Disease TreatmentPolysaccharide Natural Products
, increased the content of microbial metabolites SCFAs in the colon and increased the level of occludin that repairs the intestinal barrier of PD mice. In conclusion, this study is expected to provide a theoretical basis for the development and application of functional products with GEP from the perspective of neuroprotective effects.
69
Staging of brain pathology related to sporadic Parkinson’s disease
Heiko Braak, Kelly Del Tredici, Udo Rüb et al. · Neurobiology of Aging · 2002 · 10.8K citations
Medicine, Neurology, Neuroscience +13
Enterotypes of the human gut microbiome
Manimozhiyan Arumugam, Jeroen Raes, Éric Pelletier et al. · Nature · 2011 · 7.6K citations · Full text
Gut microbiota are related to Parkinson's disease and clinical phenotype
Filip Scheperjans, Velma T. E. Aho, Pedro A. B. Pereira et al. · Movement Disorders · 2014 · 2K citations · Full text